Am. Morin et al., MITRAL-INSUFFICIENCY CAUSED BY SYSTEMIC LUPUS-ERYTHEMATOSUS REQUIRINGVALVE-REPLACEMENT - 3 CASE-REPORTS AND A REVIEW OF THE LITERATURE, The thoracic and cardiovascular surgeon, 44(6), 1996, pp. 313-316
The increase of mitral valve insufficiency associated with systemic lu
pus erythematosus (SLE) seems to be related to the treatment with cort
icosteroids. Corticosteroids heal Libman-Sacks endocarditis, but there
by they lead to fibrotic, retracted leaflet tissue and thus to severe
valvular dysfunction. We present three patients with SLE who unterwent
mitral valve replacement due to severe mitral insufficiency. All had
been treated with corticosteroids for several years prior to the surgi
cal intervention. Macroscopic and microscopic examination of the valve
s revealed no active endocarditis. Instead, fibrotic, retracted, and c
alcified valve leaflets could be observed in two cases, and ballooned
and fibrotic leaflets in the third case. We compare our patients to 25
cases with SLE reported in the literature so far, who also had to be
submitted to mitral valve replacement. Postoperative outcome was uneve
ntful in most cases and allows surgical intervention to be considered
as a feasible treatment without major risk in patients with compensate
d organ function.